ER-KANG Pharmaceutical’s subsidiary gets production qualification for eight APIs

Summary: On 4 February, ER-KANG Pharmaceutical announced that its subsidiary, Xiangyikang, had receiveda notice on the results of GMP inspection issued by the Hunan Provincial Medical Products Administration. Eight APIs products of Xiangyikang confor...

Vitamins China E-News 202002

www.cnchemicals.com